AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms, 2022, Maëva et al
Discussion in ''Conditions related to ME/CFS' news and research' started by Andy, Feb 1, 2022.
Discussion in ''Conditions related to ME/CFS' news and research' started by Andy, Feb 1, 2022.